The uptick in the usage of GLP-1 drugs for weight loss, including Mounjaro and Ozempic, are affecting Americans' restaurant dining habits. Restaurants were already going through it as they tried to recover from the Covid-19 pandemic. Now, that attempt to stay afloat might be all the more in danger of capsizing.
GLP-1s, meet restaurant culture Analysts at Morgan Stanley Research posit that approximately 24 million Americans — 7% of the country's population — will be on a GLP-1 drug by 2035. And diners on a GLP-1 drug are ordering at restaurants in new ways. "I'm taking a GLP-1, and it's reduced [my] eating out by 80%," said Robert Reyes, a restaurant photographer, to San Diego magazine. Reyes is also "eating smaller amounts and ordering less."
More startling, perhaps, is the effect of GLP-1 drugs on people who are not using them. Nathaly del Carmen, a marketing manager in New York, claims that "at least one person at her table" is on a GLP-1 drug "whenever she dines out," said The New York Times. When surrounded by people on the drug, she "eats less" herself. Being around those with smaller appetites "helps with impulse control."
This change has the capacity to alter restaurants' already-thin bottom line. Last year was one of the "worst years in a long time" for the restaurant industry, as it dealt with "inflation that surged prices on almost all of their raw materials," said San Diego magazine.
Thin is not always the best kind of in Dining and eating have long been complicated endeavors in American history, ones that readily equate value with thinness. The Ozempic era muddles those endeavors further. The drugs have "revived a cultural fervor for thinness," one that has been accused of "killing off the body positivity movement," said The Guardian.
Manipulating our bodies toward thinness "dates back to at least the Enlightenment, with distinctly racist roots," added The Guardian. It's connected to the notion that "bigger bodies lack self-control and refinement," said Sabrina Strings, a professor of Black studies at the University of California, Santa Barbara. GLP-1s, whether used for dining in or out, provide a "medicalized avenue for that control." |